Clinical Trials Explained

Clinical trials are the mechanism by which medical knowledge advances — how new treatments, devices, and approaches are tested for safety and effectiveness before they can be widely used. For patients, understanding how trials work, what protections apply to participants, how to find studies relevant to their condition, and what questions to ask before enrolling is valuable whether you are actively considering participation or simply want to understand how research becomes medicine.

What clinical trials are and why they exist

A clinical trial is a structured research study conducted in human volunteers to evaluate whether an intervention — a drug, a medical device, a surgical procedure, a behavioral program, or a diagnostic tool — is safe, effective, or superior to existing alternatives. Without clinical trials, there would be no reliable way to know whether a new treatment works or is safe — anecdotal reports and laboratory results alone cannot establish this.

Trials are conducted under federal regulations, overseen by the Food and Drug Administration (FDA) and, for federally funded research, by the Department of Health and Human Services Office for Human Research Protections (OHRP). They must follow a detailed protocol that specifies the research question, who can participate, what interventions will be tested, what will be measured, and how data will be analyzed.

Trial phases

Clinical trials for drugs and biologics typically proceed through sequential phases:

Phase 1: The first human testing of a new treatment, usually in a small number of volunteers (often healthy volunteers, sometimes patients when the condition warrants it). The primary focus is safety — determining how the body handles the treatment, what doses are tolerable, and what side effects occur.

Phase 2: Testing in a larger group of patients with the condition of interest. The focus expands to include early signs of effectiveness and continues to evaluate safety. Phase 2 trials help determine appropriate dosing ranges and identify which patient populations may benefit.

Phase 3: Larger, randomized controlled trials comparing the new treatment against a standard treatment (or placebo where no standard exists). These trials — sometimes involving hundreds to thousands of participants across multiple sites — provide the primary evidence of effectiveness and safety needed for regulatory approval.

Phase 4: Post-marketing studies conducted after a treatment has received regulatory approval. They continue to monitor safety and effectiveness in larger, more diverse populations and in real-world conditions.

Ethical protections for participants

Federal regulations governing human research — codified in 45 CFR 46 (the Common Rule) and 21 CFR 50 and 56 for FDA-regulated research — establish a framework of protections for research participants:

Institutional Review Board (IRB) oversight: Every clinical trial must be reviewed and approved by an independent ethics committee (IRB) before it can begin, and the IRB monitors the trial during its conduct. IRBs evaluate whether the risks are justified by the potential benefits and whether participants will be appropriately protected and informed.

Informed consent: Before enrolling in a trial, you must receive a thorough explanation of the study — its purpose, procedures, duration, risks, potential benefits, alternatives, and your rights as a participant. You must have the opportunity to ask questions and must sign a consent form documenting your agreement. Informed consent is not a one-time event — you can ask questions and withdraw at any time during the trial.

Right to withdraw: You can withdraw from a clinical trial at any time for any reason, without penalty and without affecting your access to standard care. Withdrawing from a research study does not affect your relationship with your regular healthcare providers.

Confidentiality: Your research data must be protected. In most trials, your medical information is identified by a code rather than your name in the research data. Researchers are prohibited from disclosing your participation without your consent.

Insurance coverage for trial participation

The ACA requires most health plans to cover the routine costs of care associated with qualifying clinical trials. Routine costs are the services — lab tests, doctor visits, hospitalizations — that you would receive as part of your standard medical care for your condition, regardless of whether you were in a trial. Plans cannot:

• Deny or limit coverage solely because you are participating in a qualifying trial
• Terminate coverage because you are participating
• Discriminate against you based on trial enrollment

However, insurance does not cover the experimental drug or device itself (typically funded by the trial sponsor), travel costs, or services that are only needed because of the research protocol (such as extra study visits beyond standard care).

Before enrolling, ask both the trial coordinator and your insurer which costs will be covered by each party.

Finding a clinical trial

ClinicalTrials.gov, maintained by the National Library of Medicine (part of NIH), is the central registry for clinical trials conducted in the US and worldwide. The registry contains information about trials’ purposes, eligibility criteria, locations, phases, and status (recruiting, not yet recruiting, completed). You can search by:

• Medical condition or disease
• Treatment or intervention
• Geographic location or distance
• Age group and other eligibility factors

Your own physician is another important resource — they may be aware of trials relevant to your specific diagnosis and can help evaluate whether a trial is appropriate for you based on your full medical history.